Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery

Transplant International

Volumn 15, Issue 12, 2002, Pages 649-654

  Banner, Nicholas R ^a   David, Olivier J ^b   Leaver, Neil ^a   Davis, Julie ^a   Breen, Jane ^a   Johnston, Atholl ^b   Yacoub, Magdi H ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cyclosporine; Heart transplant; Pharmacokinetics; Therapeutic drug monitoring

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ADRENALIN; ALLOPURINOL; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; CYCLOSPORIN A; DOPAMINE; ENOXIMONE; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; INSULIN; METHYLPREDNISOLONE; NORADRENALIN; NYSTATIN; PREDNISOLONE; SUCRALFATE; THYMOCYTE ANTIBODY;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXPOSURE; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; NASOGASTRIC TUBE; PILOT STUDY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; COLORIMETRY; CONTINENTAL POPULATION GROUPS; CYCLOSPORINE; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; POSTOPERATIVE PERIOD;

EID: 0242418252     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00125.x     Document Type: Article

References (31)

1. Banner NR, Boscoe MJ, Khaghani A (2001) Postoperative care of the heart transplant patient. In: O'Donnell JM, Nacul FE (eds) Surgical intensive care medicine. Kluwer Academic, Boston, pp 741-760
2. Barone G, Chang CT, Choc MG Jr, Klein JB, Marsh CL, Meligeni JA, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL (1996) The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group. Transplantation 61:875-880
3. Belitsky P, Levy GA, Johnston A (2000) Neoral absorption profiling: an evolution in effectiveness. Transplant Proc 32 [Suppl 3A]:45S-52S
4. Calne RY, Rolles K, White DJ, Thiru S, Evans, DB, McMaster P, Dunn DC, Craddock GN, Henderson RG, Aziz S, Lewis P (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 2:1033-1036
5. Cantarovich M, Elstein E, Varennes B de, Barkun JS (1999) Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 68:1839-1842
6. 2 monitoring to optimise cyclosporine microemulsion dosing in de novo renal transplant recipients: a safety analysis. Joint meeting of the AST/ASTS (Chicago): abstract 220
7. Dasgupta A, Saldana S, Desai M (1991) Analytical performance of EMIT cyclosporine assay evaluated. Clin Chem 37:2130-2133
8. Eisen HJ, Hobbs RE, Davis SF, Carrier M, Mancini DM, Smith A, Valantine H, Ventura H, Mehra M, Vachiery JL, Rayburn BK, Canver CC, Laufer G, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Masters R, Michaud JL, Paradis I, Renlund DG, Vanhaecke J, Mellein B, Mueller, EA (1999) Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine - results at six months after transplantation. Transplantation 68:663-671
9. max) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of Neoral and Sandimmune for liver transplantation (NOF-8). Transplantation 67:1133-1137
10. Grevel J, Welsh MS, Kahan BD (1989) Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring. Ther Drug Monit 11:246-248
11. Halloran PF, Helms LM, Kung L, Noujaim J (1999) The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 68:1356-1361
12. Jamieson NV, Tan L, Jamieson I, Trull A, Gimson AE, Alexander G, Friend PJ, Calne RY (1996) Neoral in liver transplantation. Transplant Proc 28:2229-2231
13. Johnston A, Sketris I, Marsden JT, Galustian CG, Fashola T, Taube D, Pepper J, Holt DW (1990) A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc 22:1345-1346
14. Johnston A, Kovarik JM, Mueller EA, Holt DW (1996) Predicting patients' exposure to cyclosporine. Transpl Int 9 [Suppl 1]:S305-S307
15. Johnston A, David OJ, Cooney GF (2000) Pharmacokinetic validation of Neoral absorption profiling. Transplant Proc 32 [Suppl3A]: 53S-56S
16. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725-1738
17. Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Chang C, Choc M (1994) The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients. Transplant Proc 26:2940-2943
18. Kovarik JM, Mueller EA, Bree JB van, Tetzloff W, Kutz K (1994) Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 83:444-446
19. Levy GA, Lake JR, Beauregard-Zollinger L, Prestele H, The Neoral Phase IV Study Group (2000) Improved clinical outcomes for liver transplant recipients using cyclosporine blood level monitoring based on two-hour post-dose levels (abstract). Transplantation 69:S387
20. Lindholm A, Kahan BD (1993) Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54:205-218
21. Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, Macdonald AS, McAlister V, Lawen J (2001) Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 2:828-833
22. McBride JH, Kim SS, Rodgerson DO, Reyes AF, Ota MK (1992) Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients. Clin Chem 38:2300-2306
23. Naoumov NV, Tredger JM, Steward CM, O'Grady JG, Grevel J, Niven A, Whiting B, Williams R (1989) Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction. Gut 30:391-396
24. Öllerich M, Armstrong VW, Kahan B, Shaw L, Holt DW, Yatscoff R, Lindholm A, Halloran P, Gallicano K, Wonigeit K (1995) Lake Louise consensus conference on cyclosporine monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 17:642-654
25. Oyer PE, Stinson EB, Reitz BA, Bieber CP, Jamieson SW, Shumway NE (1981) Cardiac transplantation: 1980. Transplant Proc 13:199-206
26. Pollard SG, Lear PA, Ready AR, Moore RH, Johnson RW (1999) Comparison of microemulsion and conventional formulations of cyclosporin A in preventing acute rejection in de novo kidney transplant patients. The UK Neoral Renal Study Group. Transplantation 68:1325-1331
27. Rasmussen A, Hjortrup A, Hansen B, Heslet L, Kirkegaard P (1996) Induction of immunosuppression by microemulsion cyclosporine in liver transplantation. Transplantation 62:1031-1033
28. Reichart B, Meiser B, Vigano M, Rinaldi M, Martinelli L, Yacoub M, Banner NR, Gandjbakhch I, Dorent R, Hetzer R, Hummel M (1998) European multicenter tacrolimus (FK506) heart pilot study: one-year results. European Tacrolimus Multicenter Heart Study Group. J Heart Lung Transplant 17:775-781
29. Schroeder TJ, Hariharan S, First MR (1994) Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients. Transplant Proc 26:2787-2790
30. Schumann G, Petersen D, Hoyer PF, Wonigeit K (1993) Monitoring cyclosporin A (ciclosporin, INN) concentrations in whole blood: evaluation of the EMIT assay in comparison with HPLC and RIA. Eur J Clin Chem Clin Biochem 31:381-388
31. Tredger JM (1995) Using cyclosporine Neoral immediately after liver transplantation. United Kingdom Neoral Pilot Study Group. Ther Drug Monit 17:638-641